Journal of Radiology and Radiation Therapy

Quality Control for Quantitative Evaluation of Cardiac Sympathetic Nerve Function with 123i-Metaiodobenzylguanidine

Short Communication | Open Access

  • 1. Department of Diagnostic Radiology, Kitasato University School of Medicine, Japan
+ Show More - Show Less
Corresponding Authors
Yusuke Inoue, Department of Diagnostic Radiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan, Tel: 81-42-778-8111; Fax: 81-42-778-9436

Cardiac imaging with 123I-metaiodobenzylguanidine allows assessing cardiac sympathetic nerve function and aids the prediction of prognosis in heart failure and the differential diagnosis of neurodegenerative diseases. The heart-to-mediastinum (H/M) ratio is widely used as a quantitative indicator of cardiac accumulation; however, it is susceptible to the instrumentation, imaging parameters, and data-processing methods, and quality control is essential. This article briefly discusses technical considerations, including collimator choice, correction methods, energy window settings, and selection of regions of interest, for reliable evaluation of cardiac accumulation of 123I-metaiodobenzylguanidine.


Inoue Y (2013) Quality Control for Quantitative Evaluation of Cardiac Sympathetic Nerve Function with 123i-Metaiodobenzylguanidine. J Radiol Radiat Ther 1(2): 1010.


•     123I-metaiodobenzylguanidine (MIBG)
•    Heart-to-mediastinum (H/M) ratio
•    Quantitative evaluation
•    Collimator


Cardiac sympathetic nerve function can be assessed using iodine-123 metaiodobenzylguanidine (123I-MIBG), a radioiodinated analog of norepinephrine. Anterior chest images are acquired with a gamma camera 15 minutes and 4 hours after intravenous injection of the agent. 123I-MIBG is taken up by the abundant sympathetic nerve endings in the left ventricular wall and this uptake decreases, accompanied by accelerated washout, in patients with impaired cardiac sympathetic function. The heart-to-mediastinum (H/M) ratio, the ratio of count density in the left ventricle to that in the upper mediastinum, is calculated to quantitatively assess cardiac accumulation, and a decreased H/M ratio at a late phase (i. e. , 4 hours postinjection) is regarded as an indicator of impaired cardiac sympathetic function. The H/M ratio reflects disease severity in patients with heart failure, and cardiac 123I-MIBG imaging is used to predict their prognosis [1]. Patients with Parkinson’s disease and dementia with Lewy bodies have impaired sympathetic function, and this can be used for the differential diagnosis of neurodegenerative diseases [2,3]. 123I-MIBG was recently approved by the US Food and Drug Administration to predict prognosis in heart failure. In Japan, it has long been used in routine clinical practice to evaluate cardiac diseases including heart failure, and now its main indication has been changed to the diagnosis of neurodegenerative diseases.

Although many studies have suggested the usefulness of cardiac 123I-MIBG imaging in heart failure and neurodegenerative diseases, the large variability in the estimated H/M ratios limits its clinical use [4]. The Japanese guidelines for chronic heart failure published in 2005 state that no consensus exists regarding the quantitative value of cardiac 123I-MIBG imaging despite its potential usefulness. The 2010 version omitted the description about this examination, reflecting reduced expectations. The estimated H/M ratio depends on the instrumentation, imaging parameters, and data-processing methods, which causes difficulty when comparing values from different institutions and establishing a cutoff value for diagnosis. To overcome this problem, a proposal for standardization of cardiac 123I-MIBG imaging was published by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology in 2010 [5].

Collimator choice is a critical factor in cardiac 123I-MIBG imaging. The radionuclide 123I has great potential in nuclear medicine with versatile labeling capability and an appropriate half-life; however, it has tricky physical characteristics. It emits high-energy photons of more than 400 keV, in addition to 159-keV photons to be measured. A gamma camera relies on a collimator, typically a large lead plate with many small holes, to determine the position of radioactive sources. The collimator is attached to the surface of the detector (scintillator) and faces the patient. A gamma ray can travel though the holes and reach the scintillator only when its path is parallel to the axis of the hole. Otherwise, it is stopped by the septa of the holes. This mechanism is essential for position detection; however, high-energy photons from 123I can penetrate the thin septa of a low-energy high-resolution (LEHR) collimator designed for imaging 140-keV photons from 99mTc. The sources of the photons passing through the septa are located erroneously, degrading image quality and quantitative accuracy. Medium-energy (ME) collimators have thicker septa and are less susceptible to septal penetration than LEHR collimators. The proposal for standardization [5] comments superior accuracy using ME collimators; however, LEHR collimators are still used in many centers probably because of their wide availability and the presence of much literature using this type of collimator.

Previously, we investigated the effect of collimator choice on the assessment of H/M ratios [6]. Phantom experiments indicated better quantitative accuracy using the ME collimator than using the LEHR collimator, and clinical comparisons in eight patients demonstrated that large underestimation of H/M ratios actually occurred using the LEHR collimator. Recently, we examined 40 patients using LEHR and ME collimators for a more detailed comparison [7], and confirmed image degradation (Figure 1) and severe underestimation of H/M ratios using the LEHR collimator. We propose that all values be reported with the type of collimator used because of the large influence of collimator choice on H/M ratios. Moreover, we determined a regression equation to convert the H/M ratio using the LEHR collimator to an equivalent H/M ratio using the ME collimator. After conversion using this equation, the collimator-dependent differences decreased greatly despite obvious residual errors. Although the use of an ME collimator is recommended for accurate measurement, conversion of values obtained with an LEHR collimator facilitates comparisons among institutes. A cutoff value defined based on LEHR studies can be converted to an ME-based value using the same equation. We compared the LEHR and ME collimators using a 5/8-inch crystal camera and are now studying using a 3/8-inch crystal camera, which is commonly used in nuclear medicine. The collimator specifications differ among manufactures, and the conversion equation needs to be determined for each collimator. We also examined the use of a low-medium-energy (LME) collimator, which has characteristics intermediate between LEHR and ME collimators and are widely used for 123I imaging in Japan. Although H/M ratios were still underestimated using the LME collimator, the underestimation was much smaller than that using the LEHR collimator. When the width of the energy window was reduced from the standard 20% window to a 15% window, underestimation was almost eliminated. This indicates that the width of the energy window affects the estimated H/M ratios and that measurement with an LME collimator and a 15% window is an acceptable alternative to that with an ME collimator and a 20% window.

Additional energy windows can be set for estimating photons contaminating into the main window. The triple-energy-window method, used for scatter correction, was proven to be inaccurate for estimating H/M ratios [6]. The 123I-dual-window (IDW) method assesses the degree of contamination by high-energy photons based on counts in an energy window set at a high energy level. The IDW correction neglects scatter counts from 159-keV photons and attempts to eliminate the effect of highenergy photons exclusively. In our study [7], the IDW correction partially reduced the underestimation of the H/M ratio using the LEHR collimator; however, considerable underestimation remained. Energy-window-based corrections cannot replace the use of optimal collimators.

Septal penetration still occurs using an ME collimator, although to a much lower degree than using an LEHR collimator. If its effect on H/M ratios is significant, differences in the specifications of ME collimators among manufacturers might cause differences in H/M ratios. High-energy collimators are designed for imaging 364-keV photons from 131I and are less transparent than ME collimators. Although extensive use of an HE collimator in routine clinical practice is not realistic because of its low availability, comparison between ME and HE collimators would be informative to determine whether penetration through the septa of an ME collimator has significant effects on H/M ratios.

To calculate H/M ratios, an operator draws regions of interest (ROIs) for the heart and upper mediastinum, which introduces operator-dependent variability in the estimated values. In a recent study regarding cardiac ROIs, significant changes in the size of ROIs produced only minimal changes in the H/M ratios [8]. Acceptable reproducibility in calculating H/M ratios from a given image has been stated in other reports; however, substantial operator dependence has been shown in one report [9]. The results of operator-dependent reproducibility are operator-dependent, and operator dependence is better investigated using many operators. The background of and instructions given to the operators should be defined in such studies. The borders of the organs are unclear on images acquired using an LEHR collimator due to septal penetration, which may cause difficulty in drawing ROIs. The effect of collimator choice should be considered when assessing operator-dependent reproducibility. We assume that well-defined standardization of ROI setting and instruction followed by some training would provide acceptable reproducibility in calculating H/M ratios from images obtained with LME or ME collimators, which should be tested in the future.

Typically, the heart ROI is drawn manually covering the left ventricle and includes not only its wall but also its cavity. Since the count density, total counts divided by the area, is used to calculate H/M ratios, a dilated cavity reduces the H/M ratio, even with a fixed accumulation per gram of myocardium. The effect of dilatation may not be a substantial problem in neurodegenerative diseases, but should be considered in the assessment of heart failure. Successful treatment would reduce the cavity volume, increasing the H/M ratio even without a change in accumulation. The H/M ratio in a patient with heart failure may be regarded as a combined indicator of cardiac sympathetic nerve function and left ventricular dilatation, and correction for dilatation may provide a better indicator of sympathetic function itself.

Single photon emission computed tomography (SPECT) is commonly used in cardiac nuclear medicine and is also described in the proposal for the standardization of cardiac 123I-MIBG imaging [5]. The utility of SPECT with 123I-MIBG has been indicated for the assessment of arrhythmogenic foci; however, it is questionable in heart failure and neurodegenerative diseases. Regional differences in accumulation and washout are common especially in elderly patients, and their clinical significance is unclear. Omission of SPECT is a valid option substantially reducing the burden on patients and nuclear medicine facilities. Nominal spatial resolution is better for an LEHR collimator than for an ME collimator, and one might prefer an LEHR collimator to detect focal hypoactivity clearly on SPECT images. Actually, because of marked septal penetration, the use of an LEHR collimator gives poorer SPECT images [10]. The use of an LME collimator may offer the best balance between estimation of H/M ratios and regional assessment with SPECT, if SPECT is meaningful. In this case, an ME-equivalent H/M ratio can be obtained using a 15% energy window in planar imaging.

Normal values of H/M ratios can be determined after appropriate conversion to ME-equivalent values. However, it is desirable to establish the normal range and cutoff values using the method standardized in terms of image acquisition and data processing. In establishing reference values, age-related reduction in H/M ratios should be considered [11].

In addition to the emission of high-energy photons, 123I has other tricky physical characteristics. The physical decay of 123I produces 123Te, emitting characteristic X-Rays of 27-32 keV. A dose calibrator can detect such low-energy photons, and low-energy photons are stopped by a glass container but not by a plastic syringe. As a result, the readings on a dose calibrator vary depending on the container material [12]. This effect should be considered when measuring injection doses.

Quality control is essential in all clinical practices and has paramount importance in quantitative assessment. Cardiac 123I-MIBG imaging has a great potential for contributing to patient management in cardiology and neurology, but is susceptible to technical variance. We hope that standardization of the protocol and adherence to best practices will realize its potential.


1. Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010; 3: 92-100.

2. Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: a metaanalysis. Clin Auton Res. 2012; 22: 43-55.

3. Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging. 2012; 22: 111-117.

4. van der Veen L, Scholte A, Stokkel M. Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature. Nucl Med Commun. 2010; 31: 617-628.

5. Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010; 37: 1802-1812.

6. Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol. 2003; 10: 623-632.

7. Inoue Y, Abe Y, Itoh Y, Asano Y, Kikuchi K, Sakamoto Y, et al. Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging. J Nucl Med. 2013; 54: 707-713.

8. Jacobson AF, Matsuoka DT. Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images. Eur J Nucl Med Mol Imaging. 2013; 40: 558-564.

9. Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol. 2011; 18: 82-89.

10. Inoue Y, Shirouzu I, Machida T, Yoshizawa Y, Akita F, Minami M, et al. Collimator choice in cardiac SPECT with I-123-labeled tracers. J Nucl Cardiol. 2004; 11: 433-439.

11. Sakata K, Iida K, Mochizuki N, Ito M, Nakaya Y. Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging. Circ J. 2009; 73: 310-315.

12. Jacobson AF, Centofanti R, Babalola OI, Dean B. Survey of the performance of commercial dose calibrators for measurement of ¹²³I activity. J Nucl Med Technol. 2011; 39: 302-306.

Received : 10 Aug 2013
Accepted : 10 Sep 2013
Published : 12 Sep 2013
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X